Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Sep 30;42(9):BSR20221789.
doi: 10.1042/BSR20221789.

Antimicrobial peptides with cell-penetrating activity as prophylactic and treatment drugs

Affiliations
Review

Antimicrobial peptides with cell-penetrating activity as prophylactic and treatment drugs

Gabriel Del Rio et al. Biosci Rep. .

Abstract

Health is fundamental for the development of individuals and evolution of species. In that sense, for human societies is relevant to understand how the human body has developed molecular strategies to maintain health. In the present review, we summarize diverse evidence that support the role of peptides in this endeavor. Of particular interest to the present review are antimicrobial peptides (AMP) and cell-penetrating peptides (CPP). Different experimental evidence indicates that AMP/CPP are able to regulate autophagy, which in turn regulates the immune system response. AMP also assists in the establishment of the microbiota, which in turn is critical for different behavioral and health aspects of humans. Thus, AMP and CPP are multifunctional peptides that regulate two aspects of our bodies that are fundamental to our health: autophagy and microbiota. While it is now clear the multifunctional nature of these peptides, we are still in the early stages of the development of computational strategies aimed to assist experimentalists in identifying selective multifunctional AMP/CPP to control nonhealthy conditions. For instance, both AMP and CPP are computationally characterized as amphipatic and cationic, yet none of these features are relevant to differentiate these peptides from non-AMP or non-CPP. The present review aims to highlight current knowledge that may facilitate the development of AMP's design tools for preventing or treating illness.

Keywords: antimicrobial peptides; autophagy; cell penetrating peptide; machine learning; microbiome.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no competing interests associated with the manuscript.

Figures

Figure 1
Figure 1. The relevance of multifunctional AMP for health
AMP are amphipathic and cationic endowing interaction with anionic bacterial membranes, creating pores, and directly causing cell lysis. Furthermore, AMP with CPP activities also interact with cellular components such as DNA and ATP, which possess negatively charged groups, causing a disruption of their metabolism in bacteria. In some cell types like immune cells, AMP interact with receptors and/or induce autophagy, the release of cytokines and chemokines (with intrinsic antimicrobial activity), hence, promoting a feedback loop for autophagy resulting in the encapsulation and killing of bacteria (xenophagy). By considering these multiple functions of AMP with CPP activity, it may be possible to learn how the human body controls microbiota and autophagy to improve the health of the human population. Image created using ChemDraw.

References

    1. Chen I. (2019) An antisense oligonucleotide splicing modulator to treat spinal muscular atrophy. Nat. Res. 2021, S17–S18, https://www.nature.com/articles/d42859-019-00090-4
    1. Fosgerau K. and Hoffmann T. (2015) Peptide therapeutics: current status and future directions. Drug Discov. Today 20, 122–128 10.1016/j.drudis.2014.10.003 - DOI - PubMed
    1. Scott D.E., Bayly A.R., Abell C. and Skidmore J. (2016) Small molecules, big targets: drug discovery faces the protein-protein interaction challenge. Nat. Rev. Drug Discov. 15, 533–550 10.1038/nrd.2016.29 - DOI - PubMed
    1. Villoutreix B., Bastard K., Sperandio O., Fahraeus R., Poyet J.-L. and Calvo F. (2008) In silico-in vitro screening of protein-protein interactions: towards the next generation of therapeutics. Curr. Pharm. Biotechnol. 9, 103–122 10.2174/138920108783955218 - DOI - PubMed
    1. Marr A.K., Gooderham W.J. and Hancock R.E. (2006) Antibacterial peptides for therapeutic use: obstacles and realistic outlook. Curr. Opin. Pharmacol. 6, 468–472 10.1016/j.coph.2006.04.006 - DOI - PubMed

Publication types

MeSH terms

Substances